Congress trades in Sarepta Therapeutics (SRPT)
Healthcare · Biotechnology
3 members of Congress have disclosed 4 trades in Sarepta Therapeutics (SRPT) since 2023: 1 buy and 3 sales. The most recent was disclosed on May 7, 2025.
- Trades disclosed
- 4
- Members trading
- 3
- Buys / sells
- 1 / 3
- Reported value
- $18K–$95K
Who traded SRPT
- Rep. Josh Gottheimer (D-NJ-5)1 buy · 1 sale11Aug 21, 2023
- Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)0 buys · 1 sale01May 7, 2025
- Rep. Daniel S. Goldman (D-NY-10)0 buys · 1 sale01May 19, 2023
All trades
- May 7, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Sold (full) Sarepta Therapeutics SRPT
$1K–$15K · Traded Apr 14, 2025 · disclosed May 7, 2025
- Aug 21, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Bought Sarepta Therapeutics SRPT
$1K–$15K · Traded Jul 14, 2023 · disclosed Aug 21, 2023 · Joint
- Jul 11, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold (full) Sarepta Therapeutics SRPT
$1K–$15K · Traded Jun 13, 2023 · disclosed Jul 11, 2023 · Joint
- May 19, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
Sold Sarepta Therapeutics SRPT
$15K–$50K · Traded Apr 10, 2023 · disclosed May 19, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.